Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Role of Cannabinoids in Allergic Diseases: Collegium Internationale Allergologicum (CIA) Update 2020
Alba Angelina, Mario Pérez‐Diego, Jacobo López‐Abente, et al.
International Archives of Allergy and Immunology (2020) Vol. 181, Iss. 8, pp. 565-584
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

The epithelial barrier: The gateway to allergic, autoimmune, and metabolic diseases and chronic neuropsychiatric conditions
Duygu Yazıcı, İsmail Öğülür, Yağız Pat, et al.
Seminars in Immunology (2023) Vol. 70, pp. 101846-101846
Open Access | Times Cited: 25
The Interplay between the Immune and the Endocannabinoid Systems in Cancer
Mariantonia Braile, Simone Marcella, Gianni Marone, et al.
Cells (2021) Vol. 10, Iss. 6, pp. 1282-1282
Open Access | Times Cited: 42
The Role of Regulatory T Cells in Allergic Diseases: Collegium Internationale Allergologicum (CIA) Update 2024
Leticia Martín‐Cruz, Cristina Benito‐Villalvilla, Sofía Sirvent, et al.
International Archives of Allergy and Immunology (2024) Vol. 185, Iss. 5, pp. 503-518
Open Access | Times Cited: 7
Repurposing existing drugs for COVID-19: an endocrinology perspective
Flavio Cadegiani
BMC Endocrine Disorders (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 45
Cannabinoids induce functional Tregs by promoting tolerogenic DCs via autophagy and metabolic reprograming
Alba Angelina, Mario Pérez‐Diego, Jacobo López‐Abente, et al.
Mucosal Immunology (2021) Vol. 15, Iss. 1, pp. 96-108
Open Access | Times Cited: 33
Cannabinoid receptor 2 engagement promotes group 2 innate lymphoid cell expansion and enhances airway hyperreactivity
Benjamin P. Hurrell, Doumet Georges Helou, Pedram Shafiei-Jahani, et al.
Journal of Allergy and Clinical Immunology (2021) Vol. 149, Iss. 5, pp. 1628-1642.e10
Open Access | Times Cited: 24
Cannabinoid WIN55,212-2 reprograms monocytes and macrophages to inhibit LPS-induced inflammation
Mario Pérez‐Diego, Alba Angelina, Leticia Martín‐Cruz, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 10
Cannabinoid Compounds as a Pharmacotherapeutic Option for the Treatment of Non-Cancer Skin Diseases
Robert Ramer, Burkhard Hinz
Cells (2022) Vol. 11, Iss. 24, pp. 4102-4102
Open Access | Times Cited: 14
IgE-Mediated Allergy and Asymptomatic Sensitization to Cannabis Allergens—Review of Current Knowledge and Presentation of Six Cases
Jakub Wąsik, Aleksandra Likońska, Marcin Kurowski
Medicina (2024) Vol. 60, Iss. 6, pp. 954-954
Open Access | Times Cited: 2
Effects of non‐steroidal anti‐inflammatory drugs and other eicosanoid pathway modifiers on antiviral and allergic responses: EAACI task force on eicosanoids consensus report in times of COVID‐19
Milena Sokołowska, G. Enrico Rovati, Zuzana Diamant, et al.
Allergy (2022) Vol. 77, Iss. 8, pp. 2337-2354
Open Access | Times Cited: 12
Immune Metabolism in TH2 Responses: New Opportunities to Improve Allergy Treatment — Cell Type-Specific Findings (Part 2)
Y.-J. Lin, Alexandra Goretzki, Hannah Rainer, et al.
Current Allergy and Asthma Reports (2022) Vol. 23, Iss. 1, pp. 41-52
Open Access | Times Cited: 10
Cannabinoid receptor 2 as a regulator of inflammation induced oleoylethanolamide in eosinophilic asthma
Eun-Kyung Kwon, Youngwoo Choi, Soyoon Sim, et al.
Journal of Allergy and Clinical Immunology (2023) Vol. 153, Iss. 4, pp. 998-1009.e9
Closed Access | Times Cited: 5
Cannabinoid WIN55212‐2 impairs peanut‐allergic sensitization and promotes the generation of allergen‐specific regulatory T cells
Alba Angelina, Rodrigo Jiménez‐Saiz, Mario Pérez‐Diego, et al.
Clinical & Experimental Allergy (2022) Vol. 52, Iss. 4, pp. 540-549
Open Access | Times Cited: 8
Endocannabinoid modulation of allergic responses: Focus on the control of FcεRI-mediated mast cell activation
Rubi Monserrat Osorio-Perez, Gabriela Rodrı́guez–Manzo, Zyanya P. Espinosa‐Riquer, et al.
European Journal of Cell Biology (2023) Vol. 102, Iss. 2, pp. 151324-151324
Open Access | Times Cited: 4
The cannabinoid WIN55212‐2 restores rhinovirus‐induced epithelial barrier disruption
Alba Angelina, Mar Martín‐Fontecha, Beate Rückert, et al.
Allergy (2020) Vol. 76, Iss. 6, pp. 1900-1902
Open Access | Times Cited: 11
Emerging Role of Phospholipase-Derived Cleavage Products in Regulating Eosinophil Activity: Focus on Lysophospholipids, Polyunsaturated Fatty Acids and Eicosanoids
Eva Knuplez, Eva M. Sturm, Gunther Marsche
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4356-4356
Open Access | Times Cited: 10
Adverse Reactions to Illicit Drugs (Marijuana, Opioids, Cocaine) and Alcohol
Ine I. Decuyper, Alicia Armentia, M. Blanca, et al.
The Journal of Allergy and Clinical Immunology In Practice (2021) Vol. 9, Iss. 8, pp. 3006-3014
Open Access | Times Cited: 8
The cannabinoid WIN55212‐2 suppresses effector T‐cell responses and promotes regulatory T cells in human tonsils
Alba Angelina, Mario Pérez‐Diego, Angel E. Maldonado, et al.
Allergy (2021) Vol. 77, Iss. 3, pp. 1029-1032
Open Access | Times Cited: 6
Bakuchiol and Ethyl (Linoleate/Oleate) Synergistically Modulate Endocannabinoid Tone in Keratinocytes and Repress Inflammatory Pathway mRNAs
William R. Swindell, Krzysztof Bojanowski, Parvesh Singh, et al.
JID Innovations (2022) Vol. 3, Iss. 3, pp. 100178-100178
Open Access | Times Cited: 4
Polarity scaffolds signaling in epithelial cell permeability
Lauren O’Leary, Andrea M. Tomko, Denis J. Dupré
Inflammation Research (2021) Vol. 70, Iss. 5, pp. 525-538
Closed Access | Times Cited: 4
Regulatory factors of ILC2 are therapeutic targets for lung inflammation
Lele Cui, Yajie Wang
iLABMED (2024)
Open Access
Probing molecular pathways: Illuminating the connection between COVID‐19 and Alzheimer's disease through the endocannabinoid system dynamics
Sun Q, Jinyang Gao, Ran An, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 4
Closed Access
Medicinal potential of anandamide as a representative endocannabinoid and its effect at the cellular level in skin
Adrianna Maria Piasek, Anna Sobiepanek
Elsevier eBooks (2023), pp. 541-554
Closed Access | Times Cited: 1
Could we co-opt the cannabinoid system for asthma therapy?
Óscar Palomares
Expert Review of Clinical Immunology (2023) Vol. 19, Iss. 10, pp. 1183-1186
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top